Does the presenilin 2 gene predispose to schizophrenia?

Schizophrenia Research

Volumn 109, Issue 1-3, 2009, Pages 121-129

  Zhang, Juan ^a   Chen, Jun ^a   Xu, Qi ^a   Shen, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Case control study; Clinical profiles; Gene expression; PSEN2; Schizophrenia

Indexed keywords

PRESENILIN 2;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FAMILY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRESENILIN-2; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA;

EID: 62949114257     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.01.013     Document Type: Article

References (53)

1. Almasy L., Gur R.C., Haack K., Cole S.A., Calkins M.E., Peralta J.M., Hare E., Prasad K., Pogue-Geile M.F., Nimgaonkar V., et al. A genome screen for quantitative trait loci influencing schizophrenia and neurocognitive phenotypes. Am. J. Psychiatry 165 9 (2008) 1185-1192
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. (1994), American Psychiatric Press, Washington DC
3. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 2 (2005) 263-265
4. Bassiony M.M., and Lyketsos C.G. Delusions and hallucinations in Alzheimer's disease: review of the brain decade. Psychosomatics 44 5 (2003) 388-401
5. Bittel D.C., Kibiryeva N., and Butler M.G. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome. Pediatrics 118 4 (2006) e1276-e1283
6. Bray N.J., Preece A., Williams N.M., Moskvina V., Buckland P.R., Owen M.J., and O'Donovan M.C. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum. Mol. Genet. 14 14 (2005) 1947-1954
7. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A., Rose E.A., Kral A., Yeger H., Lewis W.H., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60 3 (1990) 509-520
8. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102 24 (2005) 8627-8632
9. Cannon T.D., van Erp T.G., Huttunen M., Lonnqvist J., Salonen O., Valanne L., Poutanen V.P., Standertskjold-Nordenstam C.G., Gur R.E., and Yan M. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry 55 12 (1998) 1084-1091
10. Cardno A.G., and Gottesman II. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 97 1 (2000) 12-17
11. Chen X., Wang X., O'Neill A.F., Walsh D., and Kendler K.S. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol. Psychiatry 9 10 (2004) 962-967
12. DeRosse P., Hodgkinson C.A., Lencz T., Burdick K.E., Kane J.M., Goldman D., and Malhotra A.K. Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biol. Psychiatry 61 10 (2007) 1208-1210
13. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum. Hered. 66 2 (2008) 87-98
14. Ekelund J., Hovatta I., Parker A., Paunio T., Varilo T., Martin R., Suhonen J., Ellonen P., Chan G., Sinsheimer J.S., et al. Chromosome 1 loci in Finnish schizophrenia families. Hum. Mol. Genet. 10 15 (2001) 1611-1617
15. Ekelund J., Hennah W., Hiekkalinna T., Parker A., Meyer J., Lonnqvist J., and Peltonen L. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol. Psychiatry 9 11 (2004) 1037-1041
16. Freedman R. Schizophrenia. N. Engl. J. Med. 349 18 (2003) 1738-1749
17. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., et al. The structure of haplotype blocks in the human genome. Science 296 5576 (2002) 2225-2229
18. Gogos J.A., and Gerber D.J. Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol. Sci. 27 4 (2006) 226-233
19. Hennah W., Varilo T., Kestila M., Paunio T., Arajarvi R., Haukka J., Parker A., Martin R., Levitzky S., Partonen T., et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum. Mol. Genet. 12 23 (2003) 3151-3159
20. Hodgkinson C.A., Goldman D., Jaeger J., Persaud S., Kane J.M., Lipsky R.H., and Malhotra A.K. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am. J. Hum. Genet. 75 5 (2004) 862-872
21. Hovatta I., Varilo T., Suvisaari J., Terwilliger J.D., Ollikainen V., Arajarvi R., Juvonen H., Kokko-Sahin M.L., Vaisanen L., Mannila H., et al. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am. J. Hum. Genet. 65 4 (1999) 1114-1124
22. Hwu H.G., Liu C.M., Fann C.S., Ou-Yang W.C., and Lee S.F. Linkage of schizophrenia with chromosome 1q loci in Taiwanese families. Mol. Psychiatry 8 4 (2003) 445-452
23. Ide M., Muratake T., Yamada K., Iwayama-Shigeno Y., Iwamoto K., Takao H., Toyota T., Kaneko N., Minabe Y., Nakamura K., et al. Genetic and expression analyses of FZD3 in schizophrenia. Biol. Psychiatry 56 6 (2004) 462-465
24. Jacobs P.A., Hunt P.A., Mayer M., and Bart R.D. Duchenne muscular dystrophy (DMD) in a female with an X/autosome translocation: further evidence that the DMD locus is at Xp21. Am. J. Hum. Genet. 33 4 (1981) 513-518
25. Kay S.R., Opler L.A., and Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 23 1 (1988) 99-110
26. Kirov, G., Zaharieva, I., Georgieva, L., Moskvina, V., Nikolov, I., Cichon, S., Hillmer, A., Toncheva, D., Owen, M.J., O'Donovan, M.C., in press. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol. Psychiatry (Mar 11: 1-8 (Electronic Publication)).
27. Law A.J., Kleinman J.E., Weinberger D.R., and Weickert C.S. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet. 16 2 (2007) 129-141
28. Lee W.H., Bookstein R., Hong F., Young L.J., Shew J.Y., and Lee E.Y. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235 4794 (1987) 1394-1399
29. Lee H.J., Jung K.M., Huang Y.Z., Bennett L.B., Lee J.S., Mei L., and Kim T.W. Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. J. Biol. Chem. 277 8 (2002) 6318-6323
30. Lencz T., Morgan T.V., Athanasiou M., Dain B., Reed C.R., Kane J.M., Kucherlapati R., and Malhotra A.K. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol. Psychiatry 12 6 (2007) 572-580
31. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 5226 (1995) 973-977
32. Liu H., Abecasis G.R., Heath S.C., Knowles A., Demars S., Chen Y.J., Roos J.L., Rapoport J.L., Gogos J.A., and Karayiorgou M. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 26 (2002) 16859-16864
33. Liu H., Heath S.C., Sobin C., Roos J.L., Galke B.L., Blundell M.L., Lenane M., Robertson B., Wijsman E.M., Rapoport J.L., et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 6 (2002) 3717-3722
34. Mah S., Nelson M.R., Delisi L.E., Reneland R.H., Markward N., James M.R., Nyholt D.R., Hayward N., Handoko H., Mowry B., et al. Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol. Psychiatry 11 5 (2006) 471-478
35. Medalia A., and Thysen J. Insight into neurocognitive dysfunction in Schizophrenia. Schizophr. Bull. 34 6 (2008) 1221-1230
36. Mueser K.T., and McGurk S.R. Schizophrenia. Lancet 363 9426 (2004) 2063-2072
37. Mukai J., Liu H., Burt R.A., Swor D.E., Lai W.S., Karayiorgou M., and Gogos J.A. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat. Genet. 36 7 (2004) 725-731
38. Owen M.J., Williams N.M., O, and ' Donovan M.C. The molecular genetics of schizophrenia: new findings promise new insights. Mol. Psychiatry 9 1 (2004) 14-27
39. Potkin, S.G., Turner, J.A., Fallon, J.A., Lakatos, A., Keator, D.B., Guffanti, G., Macciardi, F., in press. Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia. Mol. Psychiatry. (Dec 9: 1-13 (Electronic Publication)).
40. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376 6543 (1995) 775-778
41. Roperch J.P., Alvaro V., Prieur S., Tuynder M., Nemani M., Lethrosne F., Piouffre L., Gendron M.C., Israeli D., Dausset J., et al. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat. Med. 4 7 (1998) 835-838
42. Sardi S.P., Murtie J., Koirala S., Patten B.A., and Corfas G. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127 1 (2006) 185-197
43. Shifman S., Johanneson, nnesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., Kendler K.S., Li T., O'Donovan M., O'Neill F.A., et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 4 2 (2008) e28
44. Soriano S., Kang D.E., Fu M., Pestell R., Chevallier N., Zheng H., and Koo E.H. Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J. Cell Biol. 152 4 (2001) 785-794
45. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., Gosden C., and Evans H.J. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336 8706 (1990) 13-16
46. Sullivan P.F., Lin D., Tzeng J.Y., van den Oord E., Perkins D., Stroup T.S., Wagner M., Lee S., Wright F.A., Zou F., et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol. Psychiatry 13 6 (2008) 570-584
47. Takashima A., Murayama M., Murayama O., Kohno T., Honda T., Yasutake K., Nihonmatsu N., Mercken M., Yamaguchi H., Sugihara S., et al. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. U. S. A. 95 16 (1998) 9637-9641
48. Thinakaran G., and Parent A.T. Identification of the role of presenilins beyond Alzheimer's disease. Pharmacol. Res. 50 4 (2004) 411-418
49. Wallace M.R., Marchuk D.A., Andersen L.B., Letcher R., Odeh H.M., Saulino A.M., Fountain J.W., Brereton A., Nicholson J., Mitchell A.L., et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249 4965 (1990) 181-186
50. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320 5875 (2008) 539-543
51. Wang, Y., Hu, Y., Yue, F., Zhnag, K.R., Yang, H., Ma, J.T., Xu, Q., Shen, Y., in press. Evidence of epistasis between the catechol-O-methyltransferase and aldehyde dehydrogenase 3B1 genes in paranoid schizophrenia. Biol. Psychiatry.
52. Wei J., and Hemmings G.P. The NOTCH4 locus is associated with susceptibility to schizophrenia. Nat. Genet. 25 4 (2000) 376-377
53. Xie L., Ye L., Ju G.Z., Xu Q., Zhang X., Liu Z.L., Shi J.P., Yu Y.Q., Wang Z.Q., Shen Y., et al. A family- and population-based study of the UFD1L gene for schizophrenia. Am. J. Med. Genet. 147B 7 (2008) 1076-1079